Work

Subcutaneous Epcoritamab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results from the Epcore CLL-1 Trial

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-146563

Authors: Arnon P. Kater, Jacob Haaber Christensen, Hans Herluf Bentzen, Carsten Utoft Niemann, Martin Hutchings, Jenny Chen, Marcia Rios, Tammy Palenski, Tommy Li, Anthony R. Mato

Institutions: Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Odense University Hospital, Aarhus University Hospital, Copenhagen University Hospital, Rigshospitalet, Genmab (United States), AbbVie (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3211648738

Cites:

Cited by: 22

Related to: 10